<p>Before the pandemic (2017-2019), MCV1 and MCV2 coverage were 91% and 88%, respectively, compared to 94% and 63% during the pandemic (2020-2022). There was no significant difference in the level change (RR: 1.0, CI: 0.79-1.26) or slope change (RR: 1.14, CI: 0.95-1.35) in MCV1 compared to pre-COVID-19. However, there was a significant decrease of 28% in MCV2 coverage following the onset of the pandemic (RR: 0.72, CI: 0.63-0.82), with no significant gradual change (RR: 0.99, CI: 0.87-1.12). Measles annual incidence was 1.0 (interquartile range [IQR]: 0.4-5) per million population before COVID-19 and increased to 14 (IQR: 2-27) during COVID-19. We estimated a significant difference in the level change in measles incidence (RR: 4.67, CI: 1.03-21.1), and the slope change (RR: 0.07, CI: 0.02-0.27).</p>